Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 January 2007, Vol. 109, No. 2, pp. 778-785.
Prepublished online as a Blood First Edition Paper on September 26, 2006; DOI 10.1182/blood-2006-04-019141.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-04-019141v1
109/2/778    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, J.
Right arrow Articles by Qu, C.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, J.
Right arrow Articles by Qu, C.-K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted April 25, 2006
Accepted August 17, 2006

SHP-2 phosphatase is required for hematopoietic cell transformation by Bcr-Abl

Jing Chen, Wen-Mei Yu, Hanako Daino, Hal E. Broxmeyer, Brian J. Druker, and Cheng-Kui Qu*

Dept of Medicine, Division of Hematology/Oncology, Case Comprehensive Cancer Center, Cleveland, OH
Walther Oncology Center & Dept of Immunology & Microbiology, Indianapolis, Indiana, USA
Howard Hughes Medical Institute, Oregon Health & Science University Cancer Institute, Portland, OR

* Corresponding author; email: cxq6{at}case.edu.

SHP-2 phosphatase forms a stable protein complex with and is heavily tyrosine-phosphorylated by the oncogenic tyrosine kinase Bcr-Abl. However, the role of SHP-2 in Bcr-Abl-mediated leukemogenesis is unclear. In the present report, we provide evidence that SHP-2 is required for hematopoietic cell transformation by Bcr-Abl. In vitro biological effects of Bcr-Abl transduction were diminished in SHP-2{Delta}/{Delta} hematopoietic cells, and the leukemic potential of Bcr-Abl transduced SHP-2{Delta}/{Delta} cells in recipient animals was compromised. Further analyses showed that Bcr-Abl protein (p210) was degraded and its oncogenic signaling greatly decreased in SHP-2{Delta}/{Delta} cells. Treatment with proteasome inhibitors or reintroduction of SHP-2 restored p210 level in Bcr-Abl transduced SHP-2{Delta}/{Delta} cells. Subsequent investigation revealed that SHP-2 interacted with heat shock protein 90, an important chaperone protein protecting p210 from proteasome-mediated degradation. The role of SHP-2 in the stability of p210 is independent of its catalytic activity. Blockade of SHP-2 expression in p210 expressing cells by antisense or small interfering RNA approaches decreased p210 level, causing cell death. Inhibition of SHP-2 enzymatic activity by overexpression of catalytically-inactive SHP-2 mutant did not destabilize p210, but enhanced serum starvation-induced apoptosis, suggesting that SHP-2 also plays an important role in downstream signaling of p210 kinase. These studies identified a novel function of SHP-2 and suggest that SHP-2 might be a useful target for controlling Bcr-Abl-positive leukemias.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Brehme, O. Hantschel, J. Colinge, I. Kaupe, M. Planyavsky, T. Kocher, K. Mechtler, K. L. Bennett, and G. Superti-Furga
Charting the molecular network of the drug target Bcr-Abl
PNAS, May 5, 2009; 106(18): 7414 - 7419.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Mitra, C. Beach, G.-S. Feng, and R. Plattner
SHP-2 is a novel target of Abl kinases during cell proliferation
J. Cell Sci., October 15, 2008; 121(20): 3335 - 3346.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
G.-M. Zou and A. Maitra
Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration
Mol. Cancer Ther., July 1, 2008; 7(7): 2012 - 2021.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Voena, C. Conte, C. Ambrogio, E. Boeri Erba, F. Boccalatte, S. Mohammed, O. N. Jensen, G. Palestro, G. Inghirami, and R. Chiarle
The Tyrosine Phosphatase Shp2 Interacts with NPM-ALK and Regulates Anaplastic Lymphoma Cell Growth and Migration
Cancer Res., May 1, 2007; 67(9): 4278 - 4286.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020